In this study, we evaluated the changes in innate and learned behaviors of DAT-KO rats under the long-term treatment with guanfacine, a α2A-adrenoceptor agonist, which is widely used in ADHD treatment. Here, SLC6A3 is linked to attention deficit-hyperactivity disorder.